NCT02627378View on ClinicalTrials.gov

Saudi Outcomes of ECMO-treated MERS-CoV Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

October 31, 2015

Conditions
MERS-CoV InfectionRefractory Hypoxemia
Interventions
OTHER

Extracorporeal Membrane Oxygenation

Patients received veno-venous Extracorporeal Membrane Oxygenation (ECMO) support

OTHER

Non Extracorporeal Membrane Oxygenation

Patients received no Extracorporeal Membrane Oxygenation (ECMO) support

Trial Locations (1)

31952

Dammam University KFHU, Khobar

All Listed Sponsors
collaborator

Ministry of Health, Saudi Arabia

OTHER_GOV

collaborator

King Abdulaziz University

OTHER

lead

Imam Abdulrahman Bin Faisal University

OTHER

NCT02627378 - Saudi Outcomes of ECMO-treated MERS-CoV Patients | Biotech Hunter | Biotech Hunter